drugset / Trial / NCT02121301

A Clinical Study to Assess the Safety and Efficacy of an Ophthalmic Solution (SkQ1) in the Treatment of Dry Eye Syndrome (DES)

NCT02121301 ↗

Phase 2 Completed 91 enrolled Mitotech, SA ORA, Inc. · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate whether SkQ1 ophthalmic solutions are safe and effective compared to placebo for the treatment of the signs and symptoms of dry eye syndrome.

Timeline

Start
2014-04
Primary completion
2014-06
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject SkQ1 Other / unclassified 0.155 ug/ml Topical
Subject SkQ1 Other / unclassified 1.55 ug/ml Topical

Indications